Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation

Summary

This is a phase 1b randomized, double-blind, placebo-controlled study in adult subjects with Coronavirus Disease 2019 (COVID-19). This clinical trial will evaluate the preliminary safety and efficacy of BM-Allo.MSC vs placebo in treating subjects with severe disease requiring ventilator support during COVID 19 infection.

Timeline

Start

2020-08-03

Primary completion

2020-09-06

Completion

2020-09-06

Outcome

Outcome not reported

Stopped: “Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention.”

Drugs

Indications